Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.55 EUR | +0.56% |
|
-0.67% | -0.67% |
06-20 | Warburg Research raises target for Drägerwerk to 64 euros - 'Buy' | DP |
06-20 | DRAEGERWERK : Warburg Research gives a Buy rating | ZD |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With a P/E ratio at 10.21 for the current year and 8.69 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.29 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.67% | 940M | - | ||
+2.98% | 211B | B | ||
+6.11% | 185B | B- | ||
+30.83% | 158B | B- | ||
+2.74% | 64.32B | A- | ||
+20.04% | 55.66B | B+ | ||
-1.92% | 48.41B | B+ | ||
-7.29% | 37.82B | A | ||
-0.92% | 35.57B | - | ||
+9.66% | 28.12B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DRW3 Stock
- DRW8 Stock
- Ratings Drägerwerk AG & Co. KGaA